Prognostic Factors for Recurrence After Pulmonary Resection of Colorectal Cancer Metastases Journal Article


Authors: Onaitis, M. W.; Petersen, R. P.; Haney, J. C.; Saltz, L.; Park, B.; Flores, R.; Rizk, N.; Bains, M. S.; Dycoco, J.; D'Amico, T. A.; Harpole, D. H.; Kemeny, N.; Rusch, V. W.; Downey, R.
Article Title: Prognostic Factors for Recurrence After Pulmonary Resection of Colorectal Cancer Metastases
Abstract: Background: This study was undertaken to review a large series of resections of colorectal pulmonary metastases in the era of modern chemotherapy. Methods: A retrospective chart review of prospectively maintained thoracic surgery databases identified 378 patients who underwent pulmonary resection for colorectal cancer metastases with curative intent from 1998 to 2007. Results: The primary site of disease was rectum (52%), left colon (26%), right colon (16%), and unknown (6%). Before thoracic recurrence, 166 patients (44%) had previously undergone resection of extrathoracic metastases. Median disease-free interval (DFI) was 24 months from the time of the primary operation. The number of metastatic deposits resected was one in 60%, two in 20%, three in 10%, and four or more in 10%. Chemotherapy was administered to 87 patients (23%) before resection and to 169 patients (45%) after resection. Three-year recurrence-free survival was 28%, and 3-year overall survival was 78%. Multivariable analysis revealed age younger than 65 years, female sex, DFI less than 1 year, and number of metastases greater than three as independent predictors of recurrence. Of 44 patients with three or more lesions and less than 1 year DFI, none was cured by operation. By contrast, recurrence-free survival was 49% at 3 years for those with one lesion and DFI greater than 1 year. Conclusions: Age younger than 65 years, female sex, DFI less than 1 year, and number of metastases greater than three predict recurrence. Medical management alone should be considered standard for patients who have both three or more pulmonary metastases and less than 1 year DFI. © 2009 The Society of Thoracic Surgeons.
Keywords: adult; cancer chemotherapy; cancer survival; controlled study; aged; aged, 80 and over; middle aged; primary tumor; retrospective studies; young adult; major clinical study; overall survival; cancer recurrence; postoperative period; fluorouracil; capecitabine; prospective study; colorectal cancer; metastasis; neoplasm recurrence, local; lung resection; lung neoplasms; pneumonectomy; retrospective study; prediction; irinotecan; colorectal neoplasms; lung metastasis; folinic acid; neoplasm metastasis; disease free interval; multivariate analysis; oxaliplatin; rectum cancer
Journal Title: Annals of Thoracic Surgery
Volume: 87
Issue: 6
ISSN: 0003-4975
Publisher: Elsevier Science, Inc.  
Date Published: 2009-06-01
Start Page: 1684
End Page: 1688
Language: English
DOI: 10.1016/j.athoracsur.2009.03.034
PUBMED: 19463577
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 14" - "Export Date: 30 November 2010" - "CODEN: ATHSA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    864 Rusch
  2. Leonard B Saltz
    790 Saltz
  3. Nabil Rizk
    139 Rizk
  4. Raja Flores
    108 Flores
  5. Bernard J Park
    263 Park
  6. Robert J Downey
    254 Downey
  7. Joseph Dycoco
    46 Dycoco
  8. Manjit S Bains
    338 Bains
  9. Nancy Kemeny
    543 Kemeny